We are developing biologics that target myostatin and activin, growth factors which are members of the Transforming Growth Factor-Beta, or TGF-β, protein superfamily. Myostatin and activin play roles in the growth and maintenance of muscle and many other body tissues.?STM 434?is a ligand trap that targets Activin A (and other related factors) and is being studied in a Phase 1 clinical study in patients with ovarian cancer and other solid tumors.
Wolcavi Biotech致力于干細胞免疫治療、分子生物學(xué) 、免疫學(xué)、體外診斷等相關(guān)領(lǐng)域的實(shí)驗需求產(chǎn)品開(kāi)發(fā)和銷(xiāo)售。主要產(chǎn)品有抗原抗體|無(wú)血清培養基|細胞培養耗材并代理銷(xiāo)售Abcam、Invitrogen(Gibco)、Roche、Sigma、R&D、Meridian等二十多家國外知名品牌。